SCHEMBL13049572

SCHEMBL13049572

COc1c(O[13CH3])ccnc1C[S+]([O-])c1nc2cc(OCF)ccc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATP4A P20648 10/20 0.42
ATP4B P51164 10/20 0.42
CYP2C9 P11712 2/20 0.41
KDM4E B2RXH2 1/20 0.41
SLC22A2 O15244 1/20 0.41
DDAH1 O94760 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
ABCB1 P08183 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
ADRA1A P35348 1/20 0.41
FASN P49327 1/20 0.41
SLC47A2 Q86VL8 1/20 0.41
SLC47A1 Q96FL8 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
RUNX1 Q01196 1/20 0.37
ATP1A1 P05023 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28912611 0.99 ATP4A (0.41) ATP4AATP4BCYP2C9KDM4ESLC22A2
SCHEMBL29667999 0.99 ATP4A (0.41) ATP4AATP4BCYP2C9KDM4ESLC22A2
SCHEMBL23988602 0.92 ATP4A (0.41) ATP4AATP4BCYP2C9KDM4ESLC22A2
SCHEMBL9835200 0.92 ATP4A (0.41) ATP4AATP4BCYP2C9KDM4ESLC22A2
SCHEMBL12644579 0.92 ATP4A (0.41) ATP4AATP4BCYP2C9KDM4ESLC22A2
SCHEMBL10052606 0.91 ATP4A (0.41) ATP4AATP4BCYP2C9KDM4ESLC22A2
SCHEMBL6021900 0.91 ATP4A (0.41) ATP4AATP4BCYP2C9KDM4ESLC22A2
SCHEMBL6879313 0.90 ATP4A (0.54) ATP4AATP4BCYP2C9KDM4ESLC22A2
SCHEMBL13049568 0.89 ATP4A (0.33) ATP4AATP4BCYP2C9KDM4ESLC22A2
SCHEMBL23988295 0.89 RUNX1 (0.51) ATP4AATP4BCYP2C9KDM4ESLC22A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7833744-B2 Methods to evaluate cytochrome P450 2C19 isoenzyme activity using a breath test CAMBRIDGE ISOTOPE LABORATORIES, INC. (US) 2010-11-16 US disclosed
US-20080085240-A1 METHOD AND COMPOSITION TO EVALUATE CYTOCHROME P450 2C19 ISOENZYME ACTIVITY USING A BREATH TEST CAMBRIDGE ISOTOPE LABORATORIES, INC. 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085240-A1 METHOD AND COMPOSITION TO EVALUATE CYTOCHROME P450 2C19 ISOENZYME ACTIVITY USING A BREATH TEST CYP2C9, CYP2C19, CYP2C18 ATP4A 908/4885ATP4B 748/4885CYP2C9 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.